AONN+ Joins Nearly 100 Patient Advocacy Organizations in Supporting HELP Copays Act

News & Updates published on April 11, 2025 in News & Updates

In recent years, patients with chronic conditions, including cancer, have faced harmful "copay diversion programs" such as copay accumulators and maximizers. These programs prevent copay assistance payments from counting toward a patient's annual deductible and out-of-pocket maximums. Once the assistance runs out, patients are left with hundreds or thousands of out-of-pocket costs, even though they should have already reached their yearly maximum.

On March 7, 2025, Sens. Roger Marshall (R-Kansas) and Tim Kaine (D-Virginia) reintroduced the Help Ensure Lower Patient (HELP) Copays Act (S.864). This bipartisan legislation will ensure vulnerable patients can access and afford the necessary and life-saving medications prescribed by their doctors.

Specifically, this legislation would:

  • Require health plans to count the value of copay assistance toward patient cost-sharing requirements; and
  • Clarify that the Affordable Care Act's (ACA) annual out-of-pocket limit applies to all prescription drugs covered in a health plan. This requires all covered drugs be defined as "essential," prohibiting "copay maximizers"

AONN+, led by our Policy & Advocacy Committee, has joined with nearly 100 members of the All Copays Count Coalition to submit a letter to Congress, thanking the sponsors for their focus on this important issue. The letter can be found here.

Read the press release from Senator Marshall.

Related Items
Colorectal Cancer Screening Update: with Andi Dwyer, MPH
News & Updates published on June 23, 2026 in News & Updates
In this interview, AONN+ Board of Trustees member Andi Dwyer discusses the American Cancer Society’s updated colorectal cancer screening guidelines, including new stool-based tests and the first-ever recommendation of an FDA-approved blood-based screening test, while emphasizing that colonoscopy and stool tests remain the most effective tools for early detection and prevention.
AONN+ Joins Pfizer’s 7th Annual Advocacy Luncheon at ASCO 2026
News & Updates published on June 23, 2026 in News & Updates
Pfizer’s 7th Annual Advocacy Luncheon at ASCO 2026 brought together advocacy leaders, including AONN+ Executive Director Candice Roth, MSN, RN, CENP, to discuss emerging cancer therapies, the role of artificial intelligence in patient-centered care, and the launch of Pfizer’s new Patient Advocacy360 partnership framework.
AONN+ Takes Part in CAR T Vision Coalition Event
News & Updates published on June 23, 2026 in News & Updates
Candice Roth, MSN, RN, CENP, and Monica Dean represented AONN+ at the launch of the first U.S. CAR T Vision to Action Blueprint, a stakeholder-driven initiative that provides practical strategies and tools to address access barriers and expand the use of CAR T-cell therapy for eligible patients nationwide by 2030.